LIFE - aTyr Pharma, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Breakdown
ttm
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Total Revenue
8,487
422
0
0
-
Operating Expense
23,729
23,400
32,820
47,145
57,940
Operating Income
-15,242
-22,978
-32,820
-47,145
-57,940
Net Non Operating Interest Income Expense
-
-
-
-
65
Other Income Expense
-632
-785
-1,695
-1,062
-29
Pretax Income
-15,874
-23,763
-34,515
-48,207
-57,904
Tax Provision
-
-
0
-
-49
Net Income Common Stockholders
-15,713
-23,603
-34,515
-48,207
-57,855
Diluted NI Available to Com Stockholders
-15,713
-23,603
-34,515
-48,207
-57,855
Basic EPS
-
-0.007
-0.0161
-0.0262
-0.0342
Diluted EPS
-
-0.007
-0.0161
-0.0262
-0.0342
Basic Average Shares
-
3,356
2,140
1,843
1,692
Diluted Average Shares
-
3,356
2,140
1,843
1,692
Total Operating Income as Reported
-15,242
-22,978
-32,820
-47,145
-57,940
Total Expenses
23,729
23,400
32,820
47,145
57,940
Net Income from Continuing & Discontinued Operation
-15,713
-23,603
-34,515
-48,207
-57,855
Normalized Income
-15,713
-23,603
-34,515
-48,207
-57,826
Net Interest Income
-
-
-
-
65
EBIT
-15,242
-22,978
-32,820
-47,145
-57,940
EBITDA
-13,854
-
-
-
-
Reconciled Depreciation
1,388
1,366
746
713
900
Net Income from Continuing Operation Net Minority Interest
-15,713
-23,603
-34,515
-48,207
-57,855
Total Unusual Items Excluding Goodwill
-
-
0
-1,062
-29
Total Unusual Items
-
-
0
-1,062
-29
Normalized EBITDA
-13,854
-21,612
-32,074
-46,432
-57,011
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
-0.0245